Refine by
Inflammatory Disease Suppliers & Manufacturers
113 companies found
based inLausanne, SWITZERLAND
AB2 Bio Ltd., located at the Innovation Park of the École Polytechnique Fédérale de Lausanne (EPFL), is a drug discovery and development company focused on developing “best in class” innovative therapies for the treatment of inflammatory diseases ...
Tadekinig alfa is a recombinant Interleukin-18 Binding Protein (r-hIL-18BP) with a high affinity for IL-18, a major inflammatory cytokine. In healthy people, there is a large excess of naturally occurring IL-18BP keeping levels of ...
based inOttawa, ONTARIO (CANADA)
MedBiome Inc. was launched in 2018 as the result of technologies developed at the University of Ottawa. MedBiome focuses on the development of Precision Microbiome Therapeutics and Precision Microbiome Nutrition that target the production of ...
based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Our research has led us to discover that patients suffering from inflammatory bowel diseases lack a crucial bacterium and, therefore, do not have a fair chance to fight their conditions. We have developed a single ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
These molecules inhibit the different members of the SIK family and have shown the potential to modulate anti-inflammatory cytokines and pro-inflammatory cytokines. Targeted and selective inhibition of SIK proteins ...
based inMountain View, CALIFORNIA (USA)
G-Tech Medical has developed a wireless wearable patch system that measures GI motility non-invasively. Over 40 million patients visit gastroenterologists for GI conditions every year. Current options for assessing gastrointestinal activity to ...
G-Tech is developing a wearable medical technology that will be used to measure gastrointestinal (GI) motility. The G-Tech system will consist of wireless, wearable electrode patches that read electrical signals at the skin surface, a smartphone app ...
based inMorrisville, NORTH CAROLINA (USA)
Locus is a clinical-stage biotechnology company developing precision medicines for therapeutic indications across infectious disease and inflammatory diseases. Once revolutionary, antibiotics are interfering with the effectiveness of novel, ...
Locus has built the most innovative tool to reach into the human body and deliver a therapeutic manufactured by the ...
based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
based inBasel, SWITZERLAND
Granite Bio is at the forefront of biotechnological innovation, concentrating on the treatment of chronic inflammatory, autoimmune, and fibrotic diseases. These conditions are prevalent as they lack effective therapeutic options, resulting in ...
based inMunich, GERMANY
Leaders in optoacoustic imaging through innovation and collaboration; Optoacoustic imaging is a very complex field, both from a technology and applications perspective. Components to master include lasers, optics, ultrasound detectors, electronics, ...
The RSOM Explorer C50 features a mobile cart system with a flexible mechanical arm for user-friendly detector positioning on the skin. Laser safety features such as a foot pedal interlock are integrated to fulfill key requirements of the clinical ...
based inTirat Carmel, ISRAEL
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time. MeMed’s interdisciplinary ...
We have been collaborating with leading clinicians, scientists and commercial partners around the globe to develop and validate a proprietary set of rapid blood tests with the aim of empowering physicians to tackle some of the most challenging ...
based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
PRODUCT: C-CAR168. INDICATION: Autoimmune. PLATFORM: CAR-T. PRECLINICAL: CD20 / BCMA. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
based inAsheville,, NORTH CAROLINA (USA)
Headquartered in Asheville, N.C., Genova Diagnostics is a global specialty clinical laboratory, pioneering a systems approach that supports healthcare providers in the personalized treatment and prevention of chronic disease. Chronic diseases are ...
A Non-Invasive Stool Biomarker of Pancreatic Exocrine Function. Pancreatic elastase is a protein-digesting enzyme exclusively produced by the human pancreas, and serves as a non-invasive stool biomarker of pancreatic exocrine function. Pancreatic ...
based inRotkreuz, SWITZERLAND
Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro ...
Immunoassay for the qualitative detection of total antibodies against HAV. Elecsys® Anti-HAV II is an immunoassay for the in vitro qualitative detection of total (IgM and IgG) antibodies to HAV in human serum and plasma. It is used as an aid to ...
based inParis, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceuticals specializes in the invention and development of specialty pharmaceutical products and novel formulation technologies. We provide formulation, analytical, and manufacturing services to pharmaceutical companies, working ...
Biological formulation development involves discovering solutions for the most bioactive, native protein delivery. It poses a myriad of challenges due to the fact biologics consist of generally large, complex molecules that complicate drug ...
based inDurham, NORTH CAROLINA (USA)
Altis Biosystems’ mission is to develop, manufacture, and sell innovative services and research tools to reduce costs and accelerate drug development with in vitro platforms that more accurately reflect native human biology. Altis Biosystems is a ...
Accurate biological screening based on real human intestinal tissue, with a standardized workflow for reliable and reproducible data, RepliGut represents ?the next generation for in vitro testing with faster actionable data. ...
based inLondon, UNITED KINGDOM
Juno Bio is for women and people with vaginas who want to learn more about their microbes. Juno Bio tests are currently exclusively intended to be used for wellness purposes. The tests we offer are not intended to diagnose or treat disease, or to ...
An overgrowth of aerobic bacteria that causes vaginal discomfort. You’ve heard of bacterial vaginosis (BV), but there’s a good chance that aerobic vaginitis (AV) just conjures up images of bacteria getting a workout in. Find out why ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
Sibofimloc is a first-in-class, orally administered small molecule that is specifically designed to reduce the inflammatory cascade underlying Crohn’s disease and remain gut-restricted, to minimize absorption ...
based inBuk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory ...
